Cargando…

The Impact of a Forced Non-Medical Switch of Inhaled Respiratory Medication Among Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Patient Survey on Experience with Switch, Therapy Satisfaction, and Disease Control

PURPOSE: Budesonide/formoterol pressurized metered-dose inhaler (pMDI) was removed from a Medicare Part D formulary, and patients switched to fluticasone-based dry powder inhaler (DPI) therapies. This study describes the experience, satisfaction, and disease control among patients with asthma or chr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gilbert, Ileen, Wada, Keiko, Burudpakdee, Chakkarin, Ghai, Chirag, Tan, Laren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445512/ https://www.ncbi.nlm.nih.gov/pubmed/32903885 http://dx.doi.org/10.2147/PPA.S242215

Ejemplares similares

Association of Nonmedical Switches in Inhaled Respiratory Medications with Disruptions in Care: A Retrospective Prescription Claims Database Analysis
por: Gilbert, Ileen, et al.
Publicado: (2021)

Potential negative consequences of non-consented switch of inhaled medications and devices in asthma patients
por: Björnsdóttir, U S, et al.
Publicado: (2013)

Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States
por: Kabadi, Shaum M., et al.
Publicado: (2019)

Effect of a Patient Support Program for Idiopathic Pulmonary Fibrosis Patients on Medication Persistence: A Retrospective Database Analysis
por: Near, Aimee M., et al.
Publicado: (2021)

Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment
por: Tervonen, Tommi, et al.
Publicado: (2020)

Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control
por: Thomas, Mike, et al.
Publicado: (2009)

Estimation of Potential Savings Associated With Switching Medication Formulation
por: Desai, Sunita M., et al.
Publicado: (2022)

A Retrospective Study of the Effectiveness of the AeroChamber Plus(®) Flow-Vu(®) Antistatic Valved Holding Chamber for Asthma Control
por: Burudpakdee, Chakkarin, et al.
Publicado: (2017)

Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues
por: Roggeri, Alessandro, et al.
Publicado: (2016)

Impact of patient programs on adherence and persistence in inflammatory and immunologic diseases: a meta-analysis
por: Burudpakdee, Chakkarin, et al.
Publicado: (2015)

Penile surgery for patients with Peyronie’s disease initially treated with collagenase clostridium histolyticum or surgery: a claims database analysis
por: Trost, Landon, et al.
Publicado: (2022)

Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch
por: Hanada, Soichiro, et al.
Publicado: (2015)

The impact of unsupervised and unconsented switch of inhalers in patients with controlled asthma – A targeted literature review
por: Albanna, Amr S., et al.
Publicado: (2023)

A pharmacist-led medication switch protocol in an academic HIV clinic: patient knowledge and satisfaction
por: Lee, Sarah S., et al.
Publicado: (2018)

The Relative Value of Anti-Obesity Medications Compared to Similar Therapies
por: Kim, Nina, et al.
Publicado: (2023)

Pharmacy switch of antipsychotic medications: patient’s perspective
por: Murawiec, Slawomir, et al.
Publicado: (2015)

Treatment Patterns and Healthcare Outcomes with Collagenase Clostridium Histolyticum vs Surgery in Peyronie's Disease: A Retrospective Claims Database Analysis
por: Trost, Landon, et al.
Publicado: (2021)

Switching costs in medical education
por: Walsh, Kieran
Publicado: (2013)

Implicit task switching in Parkinson’s disease is preserved when on medication
por: Yaffe, Jacob A., et al.
Publicado: (2020)

Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients
por: Price, David, et al.
Publicado: (2014)

Non-medical switching an unmitigated threat to patient care
por: Baum, Dr. Seth J.
Publicado: (2023)

Association Between Patient Preference for Inhaler Medications and Asthma Outcomes
por: Nakanishi, Yu, et al.
Publicado: (2022)

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
por: Muñoz Negrete, Francisco José, et al.
Publicado: (2017)

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
por: Beck, Daniel Edward Robert, et al.
Publicado: (2017)

Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder
por: Seetasith, Arpamas, et al.
Publicado: (2019)

Switching Biological Therapies in Severe Asthma
por: Scioscia, Giulia, et al.
Publicado: (2023)

Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial
por: Richter, Manuel J., et al.
Publicado: (2018)

Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis
por: Woodcock, Ashley, et al.
Publicado: (2022)

Estimating Inhaled Corticosteroid Exposure from Short-Acting β(2)-Agonist–Inhaled Corticosteroid Rescue
por: Lugogo, Njira, et al.
Publicado: (2023)

Clinical Characteristics of Patients and Factors Associated with Switching Biologics in Asthma
por: Matsumoto-Sasaki, Machiko, et al.
Publicado: (2022)

Specialist physician perspectives on non-medical switching of prescription medications
por: Costa, Olivia S., et al.
Publicado: (2020)

Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction [Corrigendum]
Publicado: (2017)

Predictors of switching antipsychotic medications in the treatment of schizophrenia
por: Nyhuis, Allen W, et al.
Publicado: (2010)

Attitudes towards the switching of anti-epileptic medications in pharmacies: the patients’ perspective
por: Bożek, Milena, et al.
Publicado: (2023)

Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial
por: Gregoriano, Claudia, et al.
Publicado: (2018)

Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
por: Kristensen, Lars Erik, et al.
Publicado: (2018)

Patient Satisfaction And Disease Control In Patients With Systemic Lupus Erythematosus Is Not Affected By Switching From Intravenous Belimumab To Subcutaneous Injections
por: Mucke, Johanna, et al.
Publicado: (2019)

c-Abl forces YAP to switch sides
por: Keshet, Rom, et al.
Publicado: (2015)

Switching Inhalers: A Practical Approach to Keep on UR RADAR
por: Kaplan, Alan, et al.
Publicado: (2020)

Reducing carbon footprint by switching to reusable soft-mist inhalers
por: Janson, Christer, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8oqd35vudkh56q2kr83fih755p